Dafna Bonneh-Barkay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dafna Bonneh-Barkay has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Clayton A. Wiley
Department of Pathology, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania
2 shared publicationsGuoji Wang
Department of Pathology, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania
2 shared publicationsStephanie J. Bissel
Department of Pathology, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania
2 shared publicationsAdam Starkey
Department of Pathology, University of Pittsburgh, Pittsburgh, PA
1 shared publicationJulia Kofler
Department of Pathology, University of Pittsburgh, Pittsburgh, PA
1 shared publicationWilliam A. LaFramboise
Department of Pathology, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania
1 shared publication
Latest Publications
- Open Access
- 1 November 2012
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 71 (11) , 948-958
Exacerbation of Experimental Autoimmune Encephalomyelitis in the Absence of Breast Regression Protein 39/Chitinase 3-Like 1
We previously reported that YKL-40, the human analog of mouse breast regression protein 39 ([BRP-39] chitinase 3-like 1), is elevated in the cerebrosp
- 1 November 2012
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 71 (11) , 948-958
Open AccessExacerbation of Experimental Autoimmune Encephalomyelitis in the Absence of Breast Regression Protein 39/Chitinase 3-Like 1
We previously reported that YKL-40, the human analog of mouse breast regression protein 39 ([BRP-39] chitinase 3-like 1), is elevated in the cerebrosp
- 11 November 2011
- Published by Wiley in Brain Pathology
- Vol. 22 (4) , 530-546
Astrocyte and Macrophage Regulation of YKL‐40 Expression and Cellular Response in Neuroinflammation
Numerous inflammatory conditions are associated with elevated YKL‐40 expression by infiltrating macrophages. Thus, we were surprised to observe minimal macrophage and abundant astrocyte expression of YKL‐40 in neuroinflammatory conditions. The aims of the current study were to better delineate this discrepancy, characterize the factors that regulate YKL‐40 expression in macrophages and astrocytes and study whether YKL‐40 expression correlates with cell morphology and/or activation state. In vitro, macrophages expressed high levels of YKL‐40 that was induced by classical activation and inhibited by alternative activation. Cytokines released from macrophages induced YKL‐40 transcription in astrocytes that was accompanied by morphological changes and altered astrocytic motility. Because coculturing of astrocytes and macrophages did not reverse this in vitro expression pattern, additional components of the in vivo central nervous system (CNS) milieu must be required to suppress macrophage and induce astrocyte expression of YKL‐40.
- 11 November 2011
- Published by Wiley in Brain Pathology
- Vol. 22 (4) , 530-546
Astrocyte and Macrophage Regulation of YKL‐40 Expression and Cellular Response in Neuroinflammation
Numerous inflammatory conditions are associated with elevated YKL‐40 expression by infiltrating macrophages. Thus, we were surprised to observe minimal macrophage and abundant astrocyte expression of YKL‐40 in neuroinflammatory conditions. The aims of the current study were to better delineate this discrepancy, characterize the factors that regulate YKL‐40 expression in macrophages and astrocytes and study whether YKL‐40 expression correlates with cell morphology and/or activation state. In vitro, macrophages expressed high levels of YKL‐40 that was induced by classical activation and inhibited by alternative activation. Cytokines released from macrophages induced YKL‐40 transcription in astrocytes that was accompanied by morphological changes and altered astrocytic motility. Because coculturing of astrocytes and macrophages did not reverse this in vitro expression pattern, additional components of the in vivo central nervous system (CNS) milieu must be required to suppress macrophage and induce astrocyte expression of YKL‐40.